Latest News
Intelligent Partnership is teaming up with the UK Business Angels Association (UKBAA) to launch the Angel Investing Accreditation – the new official qualification to promote effective investments in Britain’s small businesses.
With the numbers of angels in the UK set to grow, it's vital that new angels can access the education and resources they need to invest with confidence. Without the appropriate skills and knowledge, enthusiastic but inexperienced investors may run the risk of losing their money. For these reasons, Intelligent Partnership and the UKBAA are launching an e-learning angel investing qualification.
Intelligent Partnership is the UK’s leading provider
ClubReady, a business management software provider for the fitness and wellness industry, has closed a Series A investment from Level Equity.
Ben Levin, Founder and Partner of Level Equity, will join the company’s board of directors. ClubReady, already profitable, will use the funds to further accelerate its rapid growth by advancing development of its product platform, introducing new services, and continuing its international expansion.
ClubReady was built from the ground up as a web-based, core business system for successful fitness club operators to manage all aspects of their business. The intuitive, easy-to-use software features club management, payment processing, and CRM
CI Capital Partners has acquired a majority interest in Hero Digital, a digital consulting firm based in San Francisco. Terms of the transaction have not been disclosed. Hero’s management retains a significant equity stake in the company.
CI Capital Partners, a New York-based private equity firm, has acquired a majority interest in Hero, a digital consulting firm based in San Francisco. Terms of the transaction have not been disclosed, but
Hero’s management has retained a significant equity stake.
Hero provides strategy, experience design and engineering services to help marketers for leading brands improve the customer experience and drive business performance.
Boston-based private equity firm Bunker Hill Capital has sold its portfolio company, The Smith & Wollensky Restaurant Group (SWRG) to Danu Partners, a private investment firm based in Ireland and a sub-licensee of SWRG which opened a restaurant in London in June, 2015.
David Jacquin, Founder and Managing Director of North Point Advisors, advised Bunker Hill Capital and SWRG on the sale.
Mark DeBlois, a Managing Partner of Bunker Hill Capital, says: “It has been our privilege to work with SWRG CEO Mike Feighery and his team in opening two new locations at Atlantic Wharf, Boston and in London with
Adarza BioSystems has closed a USD5 million Series B financing. Proceeds from the financing will be used to expand production capacity in its St Peters, MO manufacturing facility and launch its first immunoassay product consumable and instrument platform.
Proceeds will also be used to accelerate development of highly sensitive assays targeting a variety of biological analytes including cytokines, antigens and small molecules. Adarza’s Arrayed Imaging Reflectometry (AIR-StripTM) will bring an unprecedented combination of performance, workflow benefits with high sensitivity, broad dynamic range, precision, assay robustness to both life science and drug development researchers as well as clinical diagnostics practitioners.
Sverica Capital Management has held the final close of its fourth private equity fund, Sverica Capital Partners Fund IV LP, which exceeded its original target, was oversubscribed and closed at its hard cap of USD275 million.
Sverica will use Fund IV to continue its strategy of investing in growing business and IT services, healthcare services and high value industrial companies that have the potential to be category leaders in their respective industries.
Dave Finley, Managing Director of Sverica, says: “We appreciate the strong support shown for Fund IV from new and key existing investors. We believe the fundraise validates Sverica’s
Spectral Edge has completed an oversubscribed GBP1.5 million second funding round. New lead investors IQ Capital and Parkwalk Advisors, along with angel investors from Cambridge Angels, Wren Capital, Cambridge Capital Group and Martlet, the Marshall of Cambridge Corporate Angel investment fund, join the Rainbow Seed Fund/Midven and Iceni in backing the company.
Spun out of the University of East Anglia (UEA) Colour Lab, Spectral Edge has developed innovative image fusion technology. This combines different types of image, ranging from the visible to invisible (such as infrared and thermal), to enhance detail, aid visual accessibility, and create ever more beautiful pictures.
Gimv today announces a EUR 4 million investment in Topas Therapeutics, a biopharma company developing a unique immunotherapy approach to treat autoimmune diseases.
This investment is part of a total Series A financing round of EUR 14 million from a consortium of specialised life sciences investors including Epidarex Capital, EMBL Ventures and Evotec AG.
Topas Therapeutics, based in Hamburg (Germany), has developed a unique technology for the induction of antigen-specific immune tolerance. This new approach has the potential to treat autoimmune diseases, allergies and drug induced immune reactions in a more efficient and safe way. The funds will be used
CMS’s 8th annual M&A Study predicts an uncertain year despite the record levels of deal value in 2015. In the study, CMS analyses over 2,000 of its non-listed European public and private company deals between 2010 and 2015.
The uncertainty is attributed to a number of grey or black swan events including the long predicted slowdown of China’s economic growth and the greatest migration to Europe for a century across a fragile Schengen zone. The report also indicates that US interest rates and the clampdown on inversion deals, the divisive US election, a more aggressive corporate tax climate and the
NVM Private Equity (NVM) has appointed Charles Winward to its investment team. Winward will be responsible for sourcing, transacting and managing VCT investments.
Winward was previously a director at IP Group plc, where he was the Managing Director of its fund management and advisory subsidiary. Over seven years at IP Group (during which time they moved from AIM to the FTSE 250), he assisted in creating and developing several spin-out technology companies from university intellectual property, with notable successes being Tracsis plc (University of Leeds), Xeros Technology plc (University of Leeds), Boxarr Limited (Universities of Southampton and Bristol) and hVivo
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
